[1] |
WU Hui-qian, NI Heng-li, ZHOU Ai-jun, YUAN Hang, LI Jian-ming.
Tumor infiltrating lymphocytes predict the efficacy of neoadjuvant chemotherapy for breast cancer
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(02): 100-105.
|
[2] |
PENG Lin-hui, CHEN Tao, XU Yun-xiu-xiu, WANG Jie, CHEN Jie, LI Yong, HUANG Pin-bo, ZHONG Guo-ping, CHEN Qian, YE Cong-ting, CHEN Ya-jin.
mFOLFOX7 venous chemotherapy plus camrelizumab and apatinib for hepatocellular carcinoma in CNLC stage Ⅲ (VIC-TRIPLET): a prospective study
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 1-6.
|
[3] |
DONG Yi-ming, SHI Chuan-ping, LIAO Jian-you.
Effects of knockdown BRIX1 on proliferation, migration and invasion of triple negative breast cancer cells
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 42-48.
|
[4] |
WU Wen-xia, ZHANG Meng.
The effect of metabolic syndrome on prognosis of non-triple negative breast cancer
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 49-53.
|
[5] |
YAN Shan-shan, LEI Wen, LI Shuai-jie, WANG Yong-nan.
Prognostic value of HIST1H4F gene methylation in triple-negative breast cancer
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 54-58.
|
[6] |
MENG Lan-lan, JIN Hao, YAO Yan-dan.
Predictive value of tumor infiltrating lymphocytes in breast cancer patients under different molecular subtypes
[J]. Lingnan Modern Clinics In Surgery, 2024, 24(01): 76-86.
|
[7] |
WAN Jian, LIU Meng-yao, LI Shuai-jie, LIU Yi-ting, LAO Xiao-xia, CHEN Yong.
Observation of bone marrow suppression and adverse reactions after chemotherapy after breast cancer surgery
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(06): 473-479.
|
[8] |
LIU Zi-fei, HUANG Peng-han, JIANG Yong-xue, ZENG Wen-feng.
Single-cell profiling reveals that chemotherapy potentiates antitumor immunity in breast cancer through spermidine metabolism modulation
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(05): 379-386.
|
[9] |
LUO Xuan, LONG Yin, HUANG Zi-qi, HE Xiao-dong, HUANG Jue, LIAO Jian-guo, ZHANG Lei.
Real-world analysis of mFOLFOX systemic chemotherapy combined with immunotherapy and targeted therapy for unresectable hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 294-301.
|
[10] |
LIU Cong-yong, ZHANG Lu, JIANG Hui-qi, GAO Min-nan, LI Jing-wen, SHI Zhan-yue, YANG Yan-qi, ZHENG Jun-meng.
Recurrent pericardial effusion from primary cardiac angiosarcoma leading to delayed diagnosis: a case report and literature review
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 337-342.
|
[11] |
WU Xiao-yong, YAN Xue-min, ZHANG Jia-yi, WEN Jin-xu, ZHU Jia, WANG Yue-xin.
Adenoid cystic carcinoma of breast: two cases and review of literature
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 343-346.
|
[12] |
QIAN Jun-lin, TANG Hong-tao, LIN Wei, HU Ze-min.
Research progress of hepatic arterial infusion chemotherapy with FOLFOX regimen
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(04): 347-352.
|
[13] |
ZHOU Hua-bin, LIU Yu-lan, WANG Zhong-chang, LI Min, ZHENG Chao.
Prognostic impact of primary tumor resection combined with chemotherapy on stage Ⅳ colorectal cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 220-229.
|
[14] |
JIN Xiao-yan, LIU Shu-qiong, LUO Shu-juan.
Discussion on general practice management model of breast cancer
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(03): 238-241.
|
[15] |
GUAN Yu-ting, ZENG Guo-bin, CHEN Jian-ping, WU Xiong-jian.
Advance of adjuvant therapy after curative resection for hepatocellular carcinoma
[J]. Lingnan Modern Clinics In Surgery, 2023, 23(02): 193-199.
|